Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 2/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.45 |
| ▸ | PDE10A | Q9Y233 | 7/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | HPGDS | O60760 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7994360 | 0.85 | GAA (0.47) | TRPV1NPC1TP53RAB9ASMN1; SMN2 | |
| SCHEMBL40698 | 0.84 | PDGFRB (0.47) | PDGFRBPDGFRAPDE10ATRPV1RAB9A | |
| SCHEMBL6115113 | 0.81 | TRPV1 (0.55) | PDGFRBPDGFRAPDE10ATRPV1MAOB | |
| SCHEMBL803417 | 0.81 | CYP1A2 (0.50) | PDGFRBPDGFRAPDE10ANPC1TP53 | |
| Ammonia Solution, Strong SCHEMBL5507007 | 0.80 | TRPV1 (0.53) | PDGFRBPDGFRAPDE10ATRPV1MAOB | |
| SCHEMBL19021253 | 0.79 | TRPV1 (0.41) | PDE10ATRPV1CNR1CNR2TLR8 | |
| SCHEMBL29115356 | 0.79 | NPC1 (0.52) | PDGFRBPDGFRATRPV1NPC1TP53 | |
| SCHEMBL24447290 | 0.79 | KDM4C (0.41) | PDGFRBPDGFRAPDE10ATRPV1NPC1 | |
| SCHEMBL9971269 | 0.79 | EGFR (0.51) | TRPV1CNR1CNR2TLR8 | |
| SCHEMBL18369967 | 0.77 | PDGFRB (0.42) | PDGFRBPDGFRAPDE10ATRPV1TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11765968-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
| US-11765968-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11765968-B2 | Organic electroluminescent materials and devices | TPR, TPO, DDT | PDGFRB 4318/4885PDGFRA 3726/4885PDE10A 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.